FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileTevogen Bio Holdings Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TVGNW
Tevogen Bio Holdings Inc. Stock AnalysisComprehensive stock analysis for Tevogen Bio Holdings Inc. (TVGNW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTVGNW
TVGNW
Tevogen Bio Holdings Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TVGNW
  1. Home
  2. Stocks
  3. Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc.

🇺🇸TVGNW•NASDAQ

Tevogen Bio Holdings Inc.

🇺🇸TVGNW•NASDAQ
Market cap
$5.60M

Your view on TVGNW

Mkt Cap
$5.60M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Tevogen Bio Holdings Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Ryan H. Saadi
Headquarters
15 Independence Blvd, Warren, NJ, US
Industry
Biotechnology
Sector
Healthcare
CEO
Ryan H. Saadi
Headquarters
15 Independence Blvd, Warren, NJ, US
Description

Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions.

The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Tevogen Bio Holdings Inc.. Starting points for Tevogen Bio Holdings Inc.: EPS -$5.59, beta 0.22 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Tevogen Bio Holdings Inc.. Trailing twelve-month EPS for Tevogen Bio Holdings Inc. stands at -$5.59. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Tevogen Bio Holdings Inc.. Tevogen Bio Holdings Inc. has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold TVGNW12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BDTXBlack Diamond Therapeutics, Inc.HealthcareNASDAQ$75.3M
BEAMBeam Therapeutics Inc.HealthcareNASDAQ$2.2B
BETR.CNBetterLife Pharma Inc.HealthcareCNQ—
BETRFBetterLife Pharma Inc.HealthcareOTC$6.4M
BHVNBiohaven Ltd.HealthcareNYSE$1.9B
BICTFBiocure Technology Inc.HealthcareOTC$379,088
BIOABioAge Labs, Inc.HealthcareNASDAQ$161.1M
BIOAFBioasis Technologies Inc.HealthcareOTC$15,883
BIORQBiora Therapeutics, Inc.HealthcarePNK—
BIT.AXBiotron LimitedHealthcareASX—
BITRFBiotron LimitedHealthcareOTC$29.2M
BIVIBioVie Inc.HealthcareNASDAQ$8.6M
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Tevogen Bio Holdings Inc., and how their positions are changing. At a $5.6M market value, institutional positions materially move Tevogen Bio Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Tevogen Bio Holdings Inc. executives and directors. Shares of Tevogen Bio Holdings Inc. have traded between $0.04 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Tevogen Bio Holdings Inc.. Coverage tracks Tevogen Bio Holdings Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Tevogen Bio Holdings Inc.

TVGNW AnalysisWeak
Past
1
Growth
2
Health
1
Profit
1
Value
1